CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Relieva™ Balloon Sinuplasty™ Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00939471
NCT00939471N/ACompleted

Clinical Evaluation of Confirm the Safety and Efficacy of Balloon Sinuplasty Devices in the Treatment of Pediatric Sinusitis

Integra LifeSciences Corporation·interventional·Posted Jul 15, 2009·Updated Jul 12, 2024

In Brief

A clinical study evaluating Relieva™ Balloon Sinuplasty™ System for Chronic Sinusitis. Completed, enrolled 44 participants across 1 site.

Detailed Summary

A non-randomized, multi-center, prospective, clinical study intended to evaluate the safety and efficacy of balloon sinuplasty devices in pediatric patients with longstanding sinusitis following failed medical management.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsAcclarent

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 15, 2009
Enrollment StartApr 1, 2007
Primary CompletionJul 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.0 years ago

Interventions

Relieva™ Balloon Sinuplasty™ Systemdevice

Balloon dilation will be performed using endoscopic equipment with video documentation capability.